The evolving landscape of first-line and subsequent therapies in EGFR-mutated NSCLC: efficacy, resistance, and tolerability

Authors

Institutions

Publication Details

Journal
Exploration of Targeted Anti-tumor Therapy
Published
2026-04-27
DOI
https://doi.org/10.37349/etat.2026.1002370
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The evolving landscape of first-line and subsequent therapies in EGFR-mutated NSCLC: efficacy, resistance, and tolerability

Floriana Morgillo, Carminia M. Della Corte, Caterina De Rosa, Faiz Ul Haq
Exploration of Targeted Anti-tumor Therapy
Lung Cancer Treatments and Mutations
article

The evolving landscape of first-line and subsequent therapies in EGFR-mutated NSCLC: efficacy, resistance, and tolerability

Floriana Morgillo, Carminia M. Della Corte, Caterina De Rosa, Faiz Ul Haq
article en

Abstract

No abstract available for this paper.
Exploration of Targeted Anti-tumor TherapyVol. 7
University of Campania "Luigi Vanvitelli" (IT)
Associazione Italiana per la Ricerca sul Cancro
Good health and well-being
Openalex Percentile: Top 12%
Lung Cancer Treatments and Mutations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.